# Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure

> **NCT03758625** · PHASE1 · COMPLETED · sponsor: **Sharon Riddler** · enrollment: 40 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** a1DC + inactivated whole autologous HIV
- **BIOLOGICAL:** a1DC + conserved HIV peptides
- **BIOLOGICAL:** a1DC + no antigen
- **BIOLOGICAL:** pgDC + inactivated whole autologous HIV
- **BIOLOGICAL:** pgDC + conserved HIV peptides
- **BIOLOGICAL:** pgDC + no antigen

## Key facts

- **NCT ID:** NCT03758625
- **Lead sponsor:** Sharon Riddler
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-02
- **Primary completion:** 2025-02-19
- **Final completion:** 2025-02-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03758625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03758625, "Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03758625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*